Volume 41, Issue 2 pp. 136-145
ORIGINAL ARTICLE

A transformational change in scintigraphic gastroesophageal reflux studies: A comparison with historic techniques

Leticia Burton

Corresponding Author

Leticia Burton

CNI Molecular Imaging & University of Notre Dame, Sydney, NSW, Australia

Correspondence

Leticia Burton, CNI Molecular Imaging, Suite 101/5 Bay Dr, Meadowbank, NSW 2114, Australia.

Email: [email protected]

Search for more papers by this author
David Joffe

David Joffe

Department of Respiratory Medicine, Royal North Shore Hospital, Sydney, NSW, Australia

Search for more papers by this author
Douglas W Mackey

Douglas W Mackey

CNI Molecular Imaging & University of Notre Dame, Sydney, NSW, Australia

Search for more papers by this author
Hans Van der Wall

Hans Van der Wall

CNI Molecular Imaging & University of Notre Dame, Sydney, NSW, Australia

Search for more papers by this author
Gregory L Falk

Gregory L Falk

Sydney Heartburn Clinic, Concord Hospital & University of Sydney, Sydney, NSW, Australia

Search for more papers by this author
First published: 06 November 2020
Citations: 3

Abstract

Background

The inclusion of scintigraphy in the diagnostic algorithm for gastroesophageal reflux is controversial due to variability in methodology and reporting. A novel scintigraphic reflux study has been developed and validated against the current standards for the diagnosis of gastroesophageal reflux disease (GORD).

Objective

To compare a new scintigraphic reflux test against historic techniques and standardised diagnostic reference tests for gastroesophageal reflux disease.

Methods

Paired scintigraphic studies were conducted in seventeen patients. All patients underwent at least one other standardised diagnostic reflux test such as 24- hour oesophageal impedance/ pH, and oesophageal manometry, barium swallow, gastroscopy or the Peptest. Patients inadvertently presented at sites B for scintigraphic reflux testing rather than at Site A which was part of an approved study. The findings from sites B did not correlate with clinical symptoms and other diagnostic reference tests from GORD. These studies were then repeated at Site A with approval from the patients. A second reflux study was performed at site A, utilising a novel technique with the capability of assessing oesophageal and extra-oesophageal disease.

Results

The Site A technique shows good concordance with the reference diagnostic tests with an accuracy of 82.4% and kappa of 0.64 (SE: 0.16, p = 0.00). Site B had an overall accuracy of 47.1% and kappa of 0.066 (SE: 0.068, p = 0.45).

Conclusion

The Site A technique shows higher accuracy than either site B or the historic reflux techniques. It has characteristics that make it an effective screening tool for assessment of local oesophageal disease and its extraoesophageal manifestations.

CONFLICT OF INTEREST

There are no conflicts of interests to declare.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.